Daily Briefing: Drug Competition Ruling, Fighting Fraud and a Potential HIV 'Cure'

Published on
July 27, 2012

Drug Competition: For years pharmaceutical companies have legally paid competitors to keep drugs off the market. But on July 16 a court ruled that this practice was anticompetitive. Because this ruling conflicts with previous court decisions, the case may be reviewed by the Supreme Court, reports Edward Wyatt for the New York Times.

Fraud: Private insurers are partnering with the federal government to crack down on health insurance fraud, reports Julie Rovner for NPR.

AIDS Cure: It looks as is three people have been "cured" of HIV using bone marrow transplant and a mild chemotherapy, reports Richard Knox for NPR.

Early Births: In Australia more babies are being born before their due date via C-sections or medical induction. These early births did not lower the risk of stillbirth, and babies scheduled early were slightly more likely to suffer from other complications, reports Kerry Grens for Reuters.

Foodborne Disease: An inventor has made a cell phone device for consumers that can detect the presence of pathogenic E. coli and salmonella in milk, reports Peter Smith for Fast Company.

Want more from Reporting on Health? Join ussign up for our newsletterlike us on Facebook or follow us on Twitter.

Image by Pranjai Manha via Flickr